Company: CRL
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001104659-25-030908
Chunk: 37

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 37
---
 ​ | ​ | ​ | ​                              | ​ | *     | ​ | ​ |
| All current executive officers and directors as a group (16 persons) | ​ | ​ | ​                                                      | ​ | 621,783(19)  | ​ | ​ | ​ | ​                              | ​ | 1.3%  | ​ | ​ |

* Less than 1%. (1) The information reported is based on a Schedule 13G/A filed with the SEC on February 13, 2024 by The Vanguard Group, Inc. Vanguard has sole voting power with respect to 0 shares, sole dispositive power with respect to 5,767,280 shares, shared voting power with respect to 62,914 shares and shared dispositive power with respect to 212,956 of the shares reported in the table. The address of Vanguard is 100 Vanguard Boulevard, Malvern, Pennsylvania 19355.

33

(2) The information reported is based on a Schedule 13G/A filed with the SEC on November 8, 2024 by BlackRock, Inc. BlackRock has sole voting power with respect to 3,854,167 shares and sole dispositive power with respect to 4,238,497 shares reported in the table. The address of BlackRock is 55 Hudson Yards, New York, New York 10001. (3) The information reported is based on a Schedule 13G filed with the SEC on November 8, 2024 in which each of Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP (collectively, “Wellington”) reported that Wellington has sole voting power with respect to 0 shares, sole dispositive power with respect to 0 shares, shared voting power with respect to 3,366,854 shares, and shared dispositive power with respect to 3,740,768 shares. The address of Wellington is 280 Congress Street, Boston, Massachusetts, 02110. (4) Includes 61,949 shares of common stock subject to options held by Mr. Foster that are exercisable within 60 days of March 21, 2025. (5) Includes 8,188 shares of common stock subject to options held by Ms. Pease that are exercisable within 60 days of March 21, 2025 and 2,593 RSUs that vest within 60 days of March 21, 2025. (6)